Article Versions Notes

Lo Buono V, D’Aleo G, Cammaroto S, De Cola MC, Palmese F, Smorto C, Marino S, Venuti G, Sessa E, Rifici C, et al. Neuropsychological Disability in the Case of Natalizumab-Related Progressive Multifocal Leukoencephalopathy. Medicina. 2022; 58(4):551. https://doi.org/10.3390/medicina58040551

Lo Buono, Viviana, Giangaetano D’Aleo, Simona Cammaroto, Maria Cristina De Cola, Francesca Palmese, Chiara Smorto, Silvia Marino, Giuseppe Venuti, Edoardo Sessa, Carmela Rifici, and et al. 2022. "Neuropsychological Disability in the Case of Natalizumab-Related Progressive Multifocal Leukoencephalopathy" Medicina 58, no. 4: 551. https://doi.org/10.3390/medicina58040551

Lo Buono, V., D’Aleo, G., Cammaroto, S., De Cola, M. C., Palmese, F., Smorto, C., Marino, S., Venuti, G., Sessa, E., Rifici, C., & Corallo, F. (2022). Neuropsychological Disability in the Case of Natalizumab-Related Progressive Multifocal Leukoencephalopathy. Medicina, 58(4), 551. https://doi.org/10.3390/medicina58040551